GE HealthCare is the world's largest pure-play medical technology company and one of the world's leading diagnostic imaging companies.
GE HealthCare reported $9.25 billion in imaging segment revenue in 2025 — confirmed, growing 4.4% — alongside $5.35 billion in Advanced Visualization Solutions and $2.9 billion in Pharmaceutical Diagnostics growing at 15.6%. The company's total 2025 revenue was $20.63 billion, making it one of the largest pure-play medical technology companies globally. GE HealthCare's Edison AI platform embeds AI across CT, MRI, ultrasound, and X-ray products and connects to a growing ecosystem of third-party AI applications. The planned $2.3 billion acquisition of Intelerad — a cloud-based enterprise imaging platform — is the most strategically significant M&A move in diagnostic imaging informatics in recent years.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Financial performance 2023-2025
• SWOT analysis
• Technological know-how and key platforms
• Latest products, programs, and AI portfolio
• M&A and partnership activity 2023-2025
• Marketing tactics and commercial strategy
• Organization and management
Table of Contents
1. Executive Summary
2. Company Overview
3. Strategic Directions
4. Financial Performance
5. SWOT Analysis
6. Technological Know-How and Key Products
7. M&A and Partnerships
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. GE HealthCare — Key Financial Metrics 2023-2025
Table 2. GE HealthCare — Revenue by Modality 2023-2025
Table 3. GE HealthCare — Revenue by Geography 2023-2025
Table 4. GE HealthCare — R&D Investment 2023-2025
Table 5. GE HealthCare — SWOT Analysis
Table 6. GE HealthCare — Key Products and Platforms 2025
Table 7. GE HealthCare — M&A Activity 2020-2025
Table 8. GE HealthCare — Key Management 2025
Table 9. GE HealthCare — Strategic Priorities 2025-2030
